Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Xia,Wang

第一单位： Department of Individualized Cancer Management, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

作者： Xia,Wang ^[1] ; Jamie K,Teer ^[2] ; Renee N,Tousignant ^[3] ; Albert M,Levin ^[4] ; David,Boulware ^[2] ; Dhananjay A,Chitale ^[5] ; Brandon M,Shaw ^[5] ; Zhihua,Chen ^[2] ; Yonghong,Zhang ^[2] ; Jaishri O,Blakeley ^[6] ; Maria T,Acosta ^[7] ; Ludwine M,Messiaen ^[8] ; Bruce R,Korf ^[8] ; Michael A,Tainsky ^[9]

作者单位： Department of Individualized Cancer Management, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ^[1] Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ^[2] Cardiology Genetics, GeneDx, Gaithersburg, Maryland. ^[3] Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan. ^[4] Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, Michigan. ^[5] The Johns Hopkins Comprehensive Neurofibromatosis Center, Brain cancer program, Johns Hopkins Hospital and Health System Cancer, Baltimore, Maryland. ^[6] Department of Pediatrics and Neurology, Gilbert Family Neurofibromatosis Institute, Children's National Health System, George Washington University, Washington, District of Columbia. ^[7] Department of Genetics, The University of Alabama at Birmingham, Birmingham, Alabama. ^[8] Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan. ^[9]